As Medtronic Plc (MDT) Stock Rose, Lazard Asset Management LLC Has Upped Position

February 20, 2018 - By Marie Mckinney

Investors sentiment increased to 1.12 in 2017 Q3. Its up 0.22, from 0.9 in 2017Q2. It increased, as 73 investors sold MDT shares while 392 reduced holdings. 109 funds opened positions while 414 raised stakes. 1.07 billion shares or 1.07% more from 1.06 billion shares in 2017Q2 were reported. 614,744 were accumulated by First Republic. Balyasny Asset Mngmt Limited Company holds 12,304 shares. Veritable Limited Partnership stated it has 0.07% of its portfolio in Medtronic plc (NYSE:MDT). Riverhead Capital Ltd Liability holds 0.03% or 8,700 shares in its portfolio. Finemark Natl Bank & Tru, Florida-based fund reported 27,966 shares. Boston Family Office Ltd Liability Co reported 8,797 shares. Sun Life Fincl reported 0.18% stake. Benedict Financial Advsr reported 58,939 shares. Fjarde Ap reported 0.48% in Medtronic plc (NYSE:MDT). Jolley Asset Management Limited Liability Corp stated it has 0.02% of its portfolio in Medtronic plc (NYSE:MDT). Naples Glob Advsrs Lc holds 0.57% or 21,836 shares in its portfolio. Guardian Capital Lp holds 97,481 shares. Cypress Asset Inc Tx has 0.44% invested in Medtronic plc (NYSE:MDT). Bell Natl Bank invested in 0.09% or 4,012 shares. Ipswich Mngmt has invested 0.11% in Medtronic plc (NYSE:MDT).

Lazard Asset Management Llc increased its stake in Medtronic Plc (MDT) by 15.57% based on its latest 2017Q3 regulatory filing with the SEC. Lazard Asset Management Llc bought 3.06 million shares as the company’s stock rose 5.51% with the market. The institutional investor held 22.73M shares of the electromedical & electrotherapeutic apparatus company at the end of 2017Q3, valued at $1.77B, up from 19.67M at the end of the previous reported quarter. Lazard Asset Management Llc who had been investing in Medtronic Plc for a number of months, seems to be bullish on the $112.76 billion market cap company. The stock increased 0.45% or $0.37 during the last trading session, reaching $83.31. About 6.86M shares traded or 28.05% up from the average. Medtronic plc (NYSE:MDT) has risen 4.04% since February 20, 2017 and is uptrending. It has underperformed by 12.66% the S&P500.

Lazard Asset Management Llc, which manages about $50.27 billion US Long portfolio, decreased its stake in Texas Instr Inc (NASDAQ:TXN) by 277,284 shares to 25,118 shares, valued at $2.25M in 2017Q3, according to the filing. It also reduced its holding in Mastercard Inc (NYSE:MA) by 47,100 shares in the quarter, leaving it with 385,336 shares, and cut its stake in Intuitive Surg (NASDAQ:ISRG).

More important recent Medtronic plc (NYSE:MDT) news were published by: which released: “3 Big Stock Charts for Monday: Activision Blizzard, Inc. (ATVI), Netflix, Inc …” on October 09, 2017, also published article titled: “Medtronic Completes Covidien Acquisition for $50B – Analyst Blog”, published: “3 Big Stock Charts for Tuesday: Hershey Co (HSY), Juniper Networks, Inc. (JNPR …” on September 05, 2017. More interesting news about Medtronic plc (NYSE:MDT) was released by: and their article: “10 Dividend Stocks to Buy With Low Yields, But Big Dividend Growth” with publication date: February 13, 2018.

Medtronic plc (NYSE:MDT) Ratings Coverage

Among 28 analysts covering Medtronic (NYSE:MDT), 18 have Buy rating, 0 Sell and 10 Hold. Therefore 64% are positive. Medtronic has $102 highest and $80.0 lowest target. $90.40’s average target is 8.51% above currents $83.31 stock price. Medtronic had 79 analyst reports since August 10, 2015 according to SRatingsIntel. The firm has “Buy” rating by Jefferies given on Tuesday, June 27. The rating was maintained by Oppenheimer with “Buy” on Monday, June 26. The rating was downgraded by Wells Fargo to “Market Perform” on Monday, October 9. The company was maintained on Monday, July 31 by Deutsche Bank. The firm has “Equal-Weight” rating given on Monday, February 5 by Morgan Stanley. On Tuesday, August 22 the stock rating was maintained by BTIG Research with “Hold”. As per Wednesday, August 23, the company rating was maintained by Needham. BMO Capital Markets maintained the stock with “Outperform” rating in Wednesday, November 23 report. Goldman Sachs upgraded Medtronic plc (NYSE:MDT) on Friday, November 13 to “Conviction Buy List” rating. The firm has “Buy” rating by SunTrust given on Monday, April 25.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: